Get In Touch

Global Clostridium Vaccines Market: Overview

The increasing government initiatives are growing awareness regarding benefits of clostridium vaccine among consumers. Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg. The increased awareness pertaining to zoonotic diseases and the rising incidence rate of clostridium family diseases are boosting the demand for clostridium vaccine globally. In developing countries, distribution of these vaccines are mainly dependent of government intervention. Whereas, in developed nations, the distribution is dependent upon veterinary hospitals and veterinary clinics. To prevent zoonotic diseases and loss of animals, governments, veterinary hospitals, and veterinary clinics are persistently commencing awareness programs.

It is estimated that the global clostridium vaccine (animal health) market will expand with a steady CAGR of 4.9% throughout the period 2016-2024. Growing with this rate, the market is most likely to reach the value of $643.5 mn by the end of 2024, from its initial value of US$418.0 mn in 2015.

clostridium vaccine market

Large Demand of Pork to Boost the Growth of Swine Segment

The global market for clostridium vaccine can be segmented on the basis of animal species into poultry, swine, caprine, ovine, and bovine. Among these, the swine segment is expected to provide most attractive opportunities for the market growth owing to large demand of pork. Furthermore, the segment is expected to expand with a significant pace due to high possibility of swine getting diagnosed with zoonotic diseases.

However, over the forecast period, the ovine segment is anticipated to project the fastest rate of growth. The increasing prevalence of diseases such as black quarter, black diseases, and blackleg are propelling growth of this sector. Furthermore, government regulations in various geographies, growing awareness among owners, and the massive increase in the world's ovine population are envisioned to surge the demand for this segment over the forecast period.

On the basis of distribution Channel, the market for clostridium vaccine can be bifurcated into retail pharmacy, veterinary research institute, veterinary hospital, and veterinary clinic. Among these, due to technological advancements and development of overall retail industry, retail pharmacy segment is foreseen to expand with an uninterrupted growth rate. In Asia Pacific, the veterinary clinic segment holds a dominant position in the market owing to augmenting government awareness pertained to clostridium diseases and their prevention, across several countries over the region.

Asia Pacific to Project Most Impressive Growth Rate Owing to Rising Prevalence of Clostridial Diseases

On the basis of geography, the clostridium vaccine (animal health) market can be divided into five key regions, namely Middle East and Africa, Latin America, Asia Pacific, Europe, and North America. OF these, the North America segment is expected to grow with a noteworthy rate due to increasing awareness among customers. The increasing demand for meat products and the decreasing arable land are other factors leading to the growth of the market within this region. The developing region, Asia Pacific is also foreseen to provide lucrative growth opportunities owing to the increased government initiatives. The increasing population of countries such as China and India are demanding for meat products. Furthermore, the rising prevalence of clostridial diseases over these countries are most likely to generate high demand for clostridium vaccines, further assisting the expansion of the global market.

Some of the prominent players operating within this market include Bayer AG, Ceva Sante Animale, Bimeda, Inc., Vibrac Corporation,  Eli Lilly and Company, Boehringer Ingelheim,  Sanofi-Aventis (Merial Animal Health), Merck Animal Health, and Zoetis, Inc.

Clostridium Vaccine (Animal Health) Market to Gain Impetus from Rising Cases of Zoonotic Diseases

Expansion in the utilization of meat and other creature inferred items has prompted an increment in pervasiveness of creature determined infections. Also, there is an ascent in speculation on domesticated animals creatures, particularly in the arising economies. These variables have affected the clostridium vaccines market well, subsequently advancing development. One more factor driving the market's development is expanding extra cash around the world.

Moreover, rising mindfulness in regards to zoonotic illnesses and the advantages of clostridium vaccines have added to the market's development. Moreover, governments are taking activities to energize the reception of clostridium vaccines. They are likewise endeavoring to fortify the conveyance organization of the vaccines, in this manner spiking clostridium vaccines market's development.

There is an ascent in the clostridium based contamination passings overall on account of treatment opposition. This is one of the conspicuous elements advancing the development of the worldwide clostridium vaccines market. Moreover, headways in the retail drug store fragment and expansion in the quantity of veterinary centers have braced the market's development.

On the drawback, there are not many controlling components that may cause a defeat in the worldwide clostridium vaccines market. Factors, for example, significant expense of medicines and the worries related with the symptoms of the vaccines may block the market's development. Regardless, expansion in government subsidizing and improvement of new items may introduce worthwhile freedoms for the market's development.

The expanding government activities are developing mindfulness with respect to advantages of clostridium vaccine among purchasers. Clostridium vaccines are utilized to give invulnerability against to an assortment of ovine and ox-like clostridial sicknesses like lockjaw, dark illness, thick kidney (enterotoxaemia), and blackleg. The expanded mindfulness relating to zoonotic illnesses and the increasing frequency pace of clostridium family sicknesses are boosting the interest for clostridium vaccine universally. In non-industrial nations, circulation of these vaccines are chiefly needy of government intercession. To forestall zoonotic infections and loss of creatures, governments, veterinary medical clinics, and veterinary facilities are determinedly starting mindfulness programs.

Global Clostridium Vaccine (Animal Health) Market: Scope of the Report

This report on the clostridium vaccine (animal health) market studies the current as well as future prospects of the market globally. Health concern related to life threatening diseases are the major concerns in the developed and developing nations.

This research report provides a detailed analysis of the clostridium vaccine (animal health) market and helps understand the various driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the market. Porter’s five forces analysis has been covered in terms of bargaining power of buyers and suppliers, threat of new entrants and substitutes, and competitive rivalry in the global clostridium vaccine (animal health) market. Market dynamics factors such as market attractiveness analysis have also been explained in order to deliver a thorough analysis of the overall competitive scenario of the global clostridium vaccine (animal health) market.

Global Clostridium Vaccine (Animal Health) Market: Segmentation

The clostridium vaccine (animal health) market has been segmented by animal species, by distribution channel and by region. The animal species segment has been sub-segmented into bovine, ovine, caprine, swine, poultry and others. The distribution channel segment has been sub-segments into veterinary clinic, veterinary hospital, veterinary research institute and retail pharmacy.

The executive summary provides detailed insights about the report and the market in general. This elaborate executive summary provides a glimpse into the present scenario of the global clostridium vaccine (animal health) market, which includes a market snapshot that provides overall information of various segments and sub-segments. The executive summary also provides overall information and data analysis of the global clostridium vaccine (animal health) market with respect to market segments based on animal species, distribution channel as well as geographic regions. The market for clostridium vaccine (animal health) has been extensively analyzed based on their usefulness, effectiveness, sales revenue and geographic presence. The market size and forecast in terms of US$ Mn for each animal species and distribution channel has been provided for the period from 2016 to 2024. This report on the clostridium vaccine (animal health) market also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Clostridium Vaccine (Animal Health) Market: Geographical and Competitive Dynamics

Geographically, the clostridium vaccine (animal health) market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2024, along with CAGR (%) for the forecast period from 2016 to 2024. The research study also incorporates the competitive scenario in these regions.

A list of recommendations has been provided for new entrants as well as existing players to help establish a strong presence in the market and increase market share. The report also profiles major players in the clostridium vaccine (animal health) market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Zoetis, Inc., Merck Animal Health, Sanofi-Aventis (Merial Animal Health), Boehringer Ingelheim, Eli Lilly and Company (Elanco Animal Healthcare), Vibrac Corporation, Bimeda, Inc., Ceva Sante Animale and Bayer AG.

The global clostridium vaccine (animal health) market is segmented as follows:

  • Global Clostridium Vaccine (Animal Health) Market Revenue, by Animal Species
    • Bovine
    • Ovine
    • Caprine
    • Swine
    • Poultry
    • Others
  • Global Clostridium Vaccine (Animal Health) Market Revenue, by Distribution Channel
    • Veterinary Clinic
    • Veterinary Hospital
    • Veterinary Research institute
    • Retail Pharmacy
  • Global Clostridium Vaccine (Animal Health) Market Revenue, by Geography
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Australia
      • New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East and Africa
      • Saudi Arabia
      • South Africa
      • Rest of Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Clostridium Vaccine Market

Buy Now